The Department of Veterans Affairs is conducting market research for a potential 5-year IDIQ contract to consolidate the supply of three specific radiopharmaceuticals (Xofigo, Illucix, and Netspot) for VA Medical Centers in Lebanon, Philadelphia, and Pittsburgh. The performance of services must occur within the geographic areas of Philadelphia, Pittsburgh, and Lebanon, Pennsylvania, due to the products' short half-life. The proposed period of performance is from April 1, 2026, through March 31, 2031. This is a sources sought notice for planning purposes only and is not a solicitation. Interested vendors must demonstrate specific capabilities and experience in providing these radiopharmaceuticals and meet stringent regulatory and licensing requirements.